HSPA5 and infection: Pharmacological inhibition or knockdown of BiP reduces viral replication in cultured cells (ZIKV, DENV, SARS-CoV-2, and HCMV) and mouse infection models (SARS-CoV-2), highlighting its pro-viral activity.